Semaglutide is mostly perfectly tolerated with equivalent dropout premiums when compared with placebo, although it could possibly be less effectively tolerated than dulaglutide (Trulicity).1,3 The most typical adverse results are nausea, vomiting, and diarrhea and can be expert by about thirty% of people, usually when the dose is amplified.Kobiety